Announcements Trials

Browse Landscape

Status

Unknown 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Other hematologic neoplasm 1 Lymphoid 1 Dermatologic 1 Breast 1

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 72 Nivolumab 49 Ipilimumab 29 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 trametinib 14 Biopsy 13 dabrafenib 11 cemiplimab 11 avelumab 11 binimetinib 10 Radiotherapy 10 Cyclophosphamide 10 CTLA-4 Antigen 9 fludarabine 7 encorafenib 7 atezolizumab 7 Radiosurgery 7 Immunoglobulin G 7 Disulfides 7 Cisplatin 7 lenvatinib 6 durvalumab 6 Paclitaxel 6 Carboplatin 6 tislelizumab 5 relatlimab 5 fludarabine phosphate 5 dostarlimab 5 Pemetrexed 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Data Collection × Dermatologic × Clear all

NCT06432660 2026-02-06

PROMPT

Duke University

Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡